Literature DB >> 8163706

Crystal violet reactions of coagulase negative staphylococci.

R Freeman1, D Burdess, S Smith.   

Abstract

Twenty four reference strains and 112 clinical isolates of coagulase negative staphylococci (CNS) were examined for their reactions in the crystal violet test. Some species gave a white reaction and others a purple reaction. Results were consistent and reproducible and each species gave only one pattern of crystal violet reaction. Within the limited variety of species represented in the clinical isolates, Staphylococcus saprophyticus and S haemolyticus gave crystal violet purple reactions, in contrast to S epidermidis, which always gave a white reaction. Investigations suggested that the mechanism of the crystal violet test in S haemolyticus may be similar to that previously described in S aureus. Further work is needed to characterise the ability of crystal violet to modify S epidermidis and other central nervous system species. The crystal violet reaction, which has strong associations with invasiveness, phage group susceptibilities, colonisation persistence abilities, and nosocomial origin in S aureus may also be useful in studies of CNS disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163706      PMCID: PMC501916          DOI: 10.1136/jcp.47.3.283

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Crystal Violet Agar as a Differential Medium for Staphylococci.

Authors:  G H Chapman; C Berens
Journal:  J Bacteriol       Date:  1935-05       Impact factor: 3.490

2.  Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures.

Authors:  K T Kleeman; T L Bannerman; W E Kloos
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

3.  Species of coagulase-negative staphylococci isolated from catheter tips from open-heart surgery patients.

Authors:  R Freeman; N Hjersing
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

4.  Crystal violet reactions of fresh clinical isolates of Staphylococcus aureus from two British hospitals.

Authors:  R Freeman; S J Hudson; D Burdess
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

5.  Rapid identification of fibronectin, vitronectin, laminin, and collagen cell surface binding proteins on coagulase-negative staphylococci by particle agglutination assays.

Authors:  M Paulsson; A Ljungh; T Wadström
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

6.  Crystal violet reactions of Staphylococcus aureus strains colonizing infants in the first six weeks.

Authors:  S J Hudson; R Freeman; D Burdess; B D Cookson
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

7.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  A study into the mechanism of the Crystal Violet reaction in Staphylococcus aureus.

Authors:  M R Barer; D Burdess; R Freeman
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

  8 in total
  2 in total

1.  In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.

Authors:  Somrita Dey; Arnab Majhi; Sayantika Mahanti; Ipsita Dey; Biswadev Bishayi
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Phenotypes and genotypes of old and contemporary porcine strains indicate a temporal change in the S. aureus population structure in pigs.

Authors:  Carmen Espinosa-Gongora; Arshnee Moodley; Urszula Lipinska; Els M Broens; Katleen Hermans; Patrick Butaye; Luc A Devriese; Freddy Haesebrouck; Luca Guardabassi
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.